Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank71
5Y CAGR+36.6%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

5Y CAGR
+36.6%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
4.7x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202218.83%
20211.76%
20209.66%
2019-115.74%
2018-60.60%
20173.96%
2016-699.93%
2015285.94%
2014-73.87%
2013-102.90%